Focal nodular hyperplasia: hepatobiliary enhancement patterns on gadoxetic-acid contrast-enhanced MRI

Abdom Imaging. 2013 Jun;38(3):490-501. doi: 10.1007/s00261-012-9916-0.

Abstract

Objectives: To assess the range of hepatobiliary enhancement patterns of focal nodular hyperplasia (FNH) after gadoxetic-acid injection, and to correlate these patterns to specific histological features.

Materials and methods: FNH lesions, imaged with Gadoxetic-acid-enhanced MRI, with either typical imaging findings on T1, T2 and dynamic-enhanced sequences or histologically proven, were evaluated for hepatobiliary enhancement patterns and categorized as homogeneously hyperintense, inhomogeneously hyperintense, iso-intense, or hypo-intense-with-ring. Available histological specimens of FNHs (surgical resection or histological biopsy), were re-evaluated to correlate histological features with observed enhancement patterns.

Results: 26 FNHs in 20 patients were included; histology was available in six lesions (four resections, two biopsies). The following distribution of enhancement patterns was observed: 10/26 homogeneously hyperintense, 4/26 inhomogeneously hyperintense, 5/26 iso-intense, 6/26 hypointense-with-ring, and 1/26 hypointense, but without enhancing ring. The following histological features associated with gadoxetic-acid uptake were identified: number and type of bile-ducts (pre-existent bile-ducts, proliferation, and metaplasia), extent of fibrosis, the presence of inflammation and extent of vascular proliferation.

Conclusion: FNH lesions can be categorized into different hepatobiliary enhancement patterns on Gadoxetic-acid-enhanced MRI, which appear to be associated with histological differences in number and type of bile-ducts, and varying the presence of fibrous tissue, inflammation, and vascularization.

MeSH terms

  • Antigens, CD34 / metabolism
  • Biliary Tract / pathology
  • Contrast Media
  • Focal Nodular Hyperplasia / diagnosis*
  • Focal Nodular Hyperplasia / metabolism
  • Gadolinium DTPA
  • Humans
  • Image Enhancement
  • Immunohistochemistry
  • Liver / pathology
  • Magnetic Resonance Imaging

Substances

  • Antigens, CD34
  • Contrast Media
  • gadolinium ethoxybenzyl DTPA
  • Gadolinium DTPA